Prevalence of serum IgG antibodies against SARS-CoV-2 among clinic staff

被引:46
作者
Schmidt, Simone B. [1 ]
Grueter, Ludwig [2 ]
Boltzmann, Melanie [1 ]
Rollnik, Jens D. [1 ]
机构
[1] Hannover Med Sch, Associated Inst, Inst Neurorehabil Res, BDH Clin Hessisch Oldendorf, Hessisch Oldendorf, Germany
[2] Nordlab, Hameln, Germany
来源
PLOS ONE | 2020年 / 15卷 / 06期
关键词
D O I
10.1371/journal.pone.0235417
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The SARS-CoV-2 pandemic threatens health care providers and society. For planning of treatment capacities, it is of major importance to obtain reliable information on infection and fatality rates of the novel coronavirus. A German community study, the so-called Heinsberg study, found a 5-fold higher infection rate (and thus a remarkably lower fatality rate) than the officially reported cases suggest. We were interested to examine the SARS-CoV-2-IgG antibody status among clinic staff of a large neurological center in Northern Germany. Blood samples and questionnaires (demographic data, medical history) were collected pseudonymously. In total, 406 out of 525 (77.3%) of our employees participated in the study. The infection rate among the staff was as high as 2.7%. Including drop-outs (missing questionnaire but test result available), the infection rate was even higher (2.9%). Only 36% of the positively tested employees did suffer from flu-like symptoms in 2020. None of the nurses-having closest and longest contact to patients-were found to be positive. Despite the fact that the infection rate among clinic staff may not be directly compared to the situation in the surrounding county (due to different testing procedures), one might hypothesize that the infection rate could be more than 30-fold higher than the number of officially reported cases for the county of Hameln-Pyrmont. The high rate of IgG-positive, asymptomatic healthcare workers might help to overcome fears in daily work.
引用
收藏
页数:8
相关论文
共 10 条
  • [1] [Anonymous], 2020, BMJ BRIT MED J, DOI DOI 10.1136/BMJ.M1036
  • [2] Bao L, 2020, REINF COULD NOT OCC, DOI [10.1101/2020.03.13.990226v1, DOI 10.1101/2020.03.13.990226V1]
  • [3] Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong
    Donnelly, CA
    Ghani, AC
    Leung, GM
    Hedley, AJ
    Fraser, C
    Riley, S
    Abu-Raddad, LJ
    Ho, LM
    Thach, TQ
    Chau, P
    Chan, KP
    Lam, TH
    Tse, LY
    Tsang, T
    Liu, SH
    Kong, JHB
    Lau, EMC
    Ferguson, NM
    Anderson, RM
    [J]. LANCET, 2003, 361 (9371) : 1761 - 1766
  • [4] Guo L, 2020, CLIN INFECT DIS, DOI [10.1093/cid/ciaa310, DOI 10.1093/CID/CIAA31032198501]
  • [5] Current concepts: The severe acute respiratory syndrome
    Peiris, JSM
    Yuen, KY
    Osterhaus, ADME
    Stohr, K
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (25) : 2431 - 2441
  • [6] Streeck H, 2020, INFECT FATALITY RATE
  • [7] CULTIVATION OF A NOVEL TYPE OF COMMON-COLD VIRUS IN ORGAN CULTURES
    TYRRELL, DAJ
    BYNOE, ML
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1965, 1 (5448): : 1467 - +
  • [8] WHO, 104 WHO
  • [9] World Health Organization, SUMM PROB SARS CAS O
  • [10] Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2
    Zhou, Guangyu
    Zhao, Qi
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2020, 16 (10): : 1718 - 1723